Regentis Biomaterials Ltd. RGNT
1.27 USD +0.08 (+6.72%)
At closeNov 9, 2026, 6:33 PM EST
1.20 -0.07 -5.51%
After hours · Nov 9, 6:33 PM ET
1.25 Day range 1.68
1.16 52-week range 15.50
- YTD
- -81.16%
- 1 year
- -83.07%
- Market cap
- 8.92M
- EPS (ttm)
- -2.46
- YTD return
- -81.16%
- 1-year return
- -83.07%
- Volume
- 220.13K
- Avg volume
- 45.29K
- Open
- 1.18
- Previous close
- 1.19
- Day's range
- 1.25 – 1.68
- 52-week range
- 1.16 – 15.50
5D +0.10 (+7.35%)
Financials — quick view
RGNT Revenue — quarterly 16.78M
RGNT Net income — quarterly -2.24M
RGNT EPS — quarterly -0.55
News
Regentis Biomaterials Strikes Distribution Deal With AMI Medical Technologies To Commercialize GelrinC In Israel 
12 Health Care Stocks Moving In Thursday's Intraday Session - 12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session 
Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Regentis Gets Japan Patent Office Notice of Allowance For Organic Solvent‑Free Protein‑Polymer Conjugate Compositions, Covering GelrinC Manufacturing Process And Ready‑to‑Use Liquid Formulation for Articular Cartilage Repair 
Regentis Biomaterials Receives European Regulatory Approval For New GelrinC Manufacturing Process - 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
Your note
Sign in to keep a note on RGNT — it syncs with the Stock Master app.